Medicine & Health

A new study led by WashU Medicine researchers takes a deep dive into inherited genetic mutations. The findings have implications for determining an individual’s inherited cancer risk and informing potential new strategies for prevention, early detection and treatment.

Researchers at WashU Medicine described, in mice, a brain pathway that connects the loss of motivation characteristic of advanced cancer to cancer-related inflammation and identified opportunities to block this pathway and restore motivation.

Researchers at Washington University have developed a method to peer into biomolecular condensates, which could lead to a better understanding of condensate functions and their impairment in cancers and neurodegeneration.

Graham A. Colditz, MD, DrPH, the Niess-Gain Professor of Surgery and director of the Public Health Sciences Division in the Department of Surgery at WashU Medicine, has been awarded the Brinker Award for Scientific Distinction in Population Science.

The National Cancer Institute, part of the National Institutes of Health (NIH), has awarded Aimilia Gastounioti, an assistant professor at WashU Medicine, a five-year $3 million grant to improve breast cancer risk assessments for Black women.

Research from WashU Medicine found a possible new treatment strategy for certain types of blood cancers.

A phase 1 clinical trial co-led by researchers at WashU Medicine found that a new type of cell-based immunotherapy was safe for patients with several types of B-cell lymphoma, a type of blood cancer.

Nusayba Bagegni, MD, an associate professor at WashU Medicine, has been awarded a 2024 Early Career Cancer Clinical Investigator Award from the National Cancer Institute (NCI), part of the National Institutes of Health (NIH).

WashU Medicine has received renewal of a prestigious National Cancer Institute grant. Led by Daniel Link, MD, it provides funding for translational research into new therapies for patients with blood cancers.

Glioblastoma is an aggressive, incurable brain cancer that is the most common malignant brain tumor in adults. New research from Washington University in St. Louis shows that glioblastoma has an internal clock and syncs its daily rhythms to match — and take advantage of — the rhythms of its host.